FDA NDC Directory · JSON-LD · Markdown

LORAZEPAM

NDC 71610-229 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAphena Pharma Solutions - Tennessee, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA203572
Dosage form / routeTABLET · ORAL
Active ingredientsLORAZEPAM (1 mg/1)
Marketing started20170324
Package count10

External sources

Source: openFDA. Public-domain (CC0).